AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35859928 — intervention group
Group type: EXPERIMENTAL
Intervention: High IL6_0 and high IL6_5 levels
Number of subjects: 135
Study 35859928 — intervention group
Group type: EXPERIMENTAL
Intervention: High IL6_0
Number of subjects: 135
Study 35859928 — intervention group
Group type: EXPERIMENTAL
Intervention: High IL6_5 level
Number of subjects: 135
Study 34182948 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal birth stories
Number of subjects: 426
Study 34182948 — intervention group
Group type: EXPERIMENTAL
Intervention: Caesarean birth stories
Number of subjects: 426
Study 36071401 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-created interventions in addition to standard of care
Number of subjects: 700
Study 36071401 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (routine clinical assessment every 3 months)
Number of subjects: 700
Study 32722250 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg Probiotic (Saccharomyces cerevisiae CNCM I-3856)
Number of subjects: 60
Study 32722250 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 mg Probiotic (Saccharomyces cerevisiae CNCM I-3856)
Number of subjects: 60
Study 32722250 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic (Saccharomyces cerevisiae CNCM I-3856)
Number of subjects: 60
Study 32722250 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 36384550 — intervention group
Group type: EXPERIMENTAL
Intervention: HLI-based self-care education program (4 sessions of 1.5 hours each)
Number of subjects: 100
Study 36384550 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 100
Study 32203735 — intervention group
Group type: EXPERIMENTAL
Intervention: Local priming
Number of subjects: 0
Study 32203735 — intervention group
Group type: COMPARATOR
Intervention: Global priming
Number of subjects: 0
Study 34313232 — intervention group
Group type: EXPERIMENTAL
Intervention: Third-generation dual-source CT scanner (group A)
Number of subjects: 131
Study 34313232 — intervention group
Group type: COMPARATOR
Intervention: Second-generation dual-source CT scanner (group B)
Number of subjects: 131
Study 32444035 — intervention group
Group type: EXPERIMENTAL
Intervention: Barberry extract (500 mg, 6 capsules daily for 3 months)
Number of subjects: 70
Study 32444035 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 35578351 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (complex intervention to encourage deprescribing antidepressants)
Number of subjects: 330
Study 35578351 — intervention group
Group type: COMPARATOR
Intervention: Control group (enhanced care as usual)
Number of subjects: 330
Study 34541630 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormonal oral contraceptive
Number of subjects: 0
Study 34541630 — intervention group
Group type: EXPERIMENTAL
Intervention: Image-guided aspiration
Number of subjects: 0
Study 34541630 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive surgery
Number of subjects: 0
Study 34541630 — intervention group
Group type: EXPERIMENTAL
Intervention: Open surgery
Number of subjects: 0
Study 34541630 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvaginal ultrasound with color Doppler
Number of subjects: 0
Study 34541630 — intervention group
Group type: EXPERIMENTAL
Intervention: CA 125 plasma level or ROMA algorithm
Number of subjects: 0
Study 32541618 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral training (n = 12)
Number of subjects: 23
Study 32541618 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral training (n = 11)
Number of subjects: 23
Study 34170781 — intervention group
Group type: EXPERIMENTAL
Intervention: COVID-19 positive patients
Number of subjects: 200
Study 34170781 — intervention group
Group type: COMPARATOR
Intervention: COVID-19 negative patients
Number of subjects: 200
Study 34170781 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with COVID-19 and VAEs
Number of subjects: 200
Study 34170781 — intervention group
Group type: COMPARATOR
Intervention: Patients without COVID-19 and VAEs
Number of subjects: 200
Study 34170781 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive ARDS in patients with COVID-19
Number of subjects: 200
Study 34170781 — intervention group
Group type: COMPARATOR
Intervention: Progressive ARDS in patients without COVID-19
Number of subjects: 200
Study 33217088 — intervention group
Group type: EXPERIMENTAL
Intervention: Current major depressive disorder
Number of subjects: 177
Study 33217088 — intervention group
Group type: EXPERIMENTAL
Intervention: Past depressive episode
Number of subjects: 177
Study 33217088 — intervention group
Group type: EXPERIMENTAL
Intervention: Recurrent depressive disorder
Number of subjects: 177
Study 33217088 — intervention group
Group type: EXPERIMENTAL
Intervention: Current depressive disorder
Number of subjects: 177
Study 35435541 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantity + Quality blended PL group (SSPlay)
Number of subjects: 79
Study 35435541 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality group with play-based recess only (Play)
Number of subjects: 79
Study 35435541 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 79
Study 35435541 — intervention group
Group type: EXPERIMENTAL
Intervention: SSPlay and Play groups combined
Number of subjects: 79
Study 35999166 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (124 patients)
Number of subjects: 250
Study 35999166 — intervention group
Group type: COMPARATOR
Intervention: Control group (126 patients)
Number of subjects: 250
Study 33478260 — intervention group
Group type: EXPERIMENTAL
Intervention: Blue-green light of 12,000 lux (experimental)
Number of subjects: 0
Study 33478260 — intervention group
Group type: COMPARATOR
Intervention: Dim red light of 5 lux (control)
Number of subjects: 0
Study 32661756 — intervention group
Group type: EXPERIMENTAL
Intervention: Dienogest (DNG) for 4 months preoperatively (group D)
Number of subjects: 70
Study 32661756 — intervention group
Group type: COMPARATOR
Intervention: Gonadotropin-releasing hormone (GnRH) agonist for 4 months preoperatively (group G)
Number of subjects: 70
Study 32661756 — intervention group
Group type: EXPERIMENTAL
Intervention: Dienogest (DNG)
Number of subjects: 70
Study 32661756 — intervention group
Group type: COMPARATOR
Intervention: Gonadotropin-releasing hormone (GnRH) agonist
Number of subjects: 70
Study 32661756 — intervention group
Group type: EXPERIMENTAL
Intervention: Dienogest (DNG) and Gonadotropin-releasing hormone (GnRH) agonist
Number of subjects: 70
Study 35644672 — intervention group
Group type: EXPERIMENTAL
Intervention: Double dosage of 23-valent pneumococcal polysaccharide vaccine (PPV23) in WLPs
Number of subjects: 139
Study 35644672 — intervention group
Group type: COMPARATOR
Intervention: Normal dosage of 23-valent pneumococcal polysaccharide vaccine (PPV23) in WLPs
Number of subjects: 139
Study 35644672 — intervention group
Group type: EXPERIMENTAL
Intervention: Double dosage of pneumococcal vaccines in KTRs
Number of subjects: 139
Study 35644672 — intervention group
Group type: COMPARATOR
Intervention: Normal dosage of pneumococcal vaccines in KTRs
Number of subjects: 139
Study 35644672 — intervention group
Group type: EXPERIMENTAL
Intervention: Double dosage of pneumococcal vaccines in WLPs
Number of subjects: 139
Study 33622389 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin (48 IU/day)
Number of subjects: 106
Study 33622389 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106
Study 32825665 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct outreach
Number of subjects: 0
Study 32825665 — intervention group
Group type: COMPARATOR
Intervention: Traditional referral
Number of subjects: 0
Study 32825665 — intervention group
Group type: COMPARATOR
Intervention: Best practice advisory (BPA)
Number of subjects: 0
Study 32825665 — intervention group
Group type: EXPERIMENTAL
Intervention: All methods combined
Number of subjects: 0
Study 34184576 — intervention group
Group type: EXPERIMENTAL
Intervention: Early lactate-guided treatment
Number of subjects: 82
Study 34184576 — intervention group
Group type: COMPARATOR
Intervention: Regular treatment (control group)
Number of subjects: 82
Study 34516655 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium (200 μg) and Vitamin E (400 units) for 3 months
Number of subjects: 60
Study 34516655 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 35656824 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor‐aspirin
Number of subjects: 6412
Study 35656824 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel‐aspirin
Number of subjects: 6412
Study 33245938 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral transcutaneous tibial nerve stimulation (TTNS)
Number of subjects: 17
Study 33245938 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticholinergics
Number of subjects: 17
Study 33245938 — intervention group
Group type: COMPARATOR
Intervention: Sham TTNS
Number of subjects: 17
Study 33439557 — intervention group
Group type: EXPERIMENTAL
Intervention: e.max Press
Number of subjects: 105
Study 33439557 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial LiSi Press
Number of subjects: 105
Study 33439557 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 105
Study 35869572 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy for 12 months
Number of subjects: 60
Study 35869572 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 33484896 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT) thrice-weekly for 12 weeks
Number of subjects: 60
Study 33484896 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide (HCTZ) daily doses of 12.5 mg for 12 weeks
Number of subjects: 60
Study 35241434 — intervention group
Group type: EXPERIMENTAL
Intervention: L-PF Dyspnoea score
Number of subjects: 542
Study 35241434 — intervention group
Group type: EXPERIMENTAL
Intervention: L-PF Cough score
Number of subjects: 542
Study 32151287 — intervention group
Group type: EXPERIMENTAL
Intervention: Wild blueberry (WBB) supplementation (253 mg anthocyanins daily for 4 weeks)
Number of subjects: 64
Study 32151287 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo supplementation
Number of subjects: 64
Study 35988194 — intervention group
Group type: EXPERIMENTAL
Intervention: Nanomaterial-loaded clarithromycin (CLA)
Number of subjects: 120
Study 35988194 — intervention group
Group type: COMPARATOR
Intervention: Clarithromycin capsules (Control)
Number of subjects: 120
Study 33080765 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrower's Ten exercises
Number of subjects: 36
Study 33080765 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 36
Study 34226933 — intervention group
Group type: EXPERIMENTAL
Intervention: Shaving waivers
Number of subjects: 10383
Study 34226933 — intervention group
Group type: COMPARATOR
Intervention: No shaving waivers (control group)
Number of subjects: 10383
Study 32918135 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 μg FA/day
Number of subjects: 622
Study 32918135 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 g creatine
Number of subjects: 622
Study 32918135 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 622
Study 32434399 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined multimarker screening for pre-eclampsia (maternal medical history, mean arterial pressure, placental growth factor, pregnancy associated plasma protein-A, Uterine artery mean pulsatility index)
Number of subjects: 0
Study 32434399 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin at a dose of 150 mg at bedtime
Number of subjects: 0
Study 34493525 — intervention group
Group type: EXPERIMENTAL
Intervention: Single session of education and exercise
Number of subjects: 152
Study 34493525 — intervention group
Group type: COMPARATOR
Intervention: Multiple sessions (6 sessions over 12 weeks) of education and exercise
Number of subjects: 152
Study 32423621 — intervention group
Group type: EXPERIMENTAL
Intervention: SBRT with immediate ADT (continuous ADT, n = 7; intermittent ADT, n = 32)
Number of subjects: 88
Study 32423621 — intervention group
Group type: EXPERIMENTAL
Intervention: SBRT with immediate ADT
Number of subjects: 88
Study 32423621 — intervention group
Group type: COMPARATOR
Intervention: SBRT with delayed ADT
Number of subjects: 88
Study 33252489 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (psychosocial counseling, systems navigation, and antiretroviral treatment)
Number of subjects: 502
Study 33252489 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 502
Study 32993604 — intervention group
Group type: EXPERIMENTAL
Intervention: PHQ-9
Number of subjects: 109
Study 616277788 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 985
Study 616277788 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 985
Study 35725486 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel design house with elevated bedrooms and permeable screened walls
Number of subjects: 1650
Study 35725486 — intervention group
Group type: COMPARATOR
Intervention: Traditional houses
Number of subjects: 1650
Study 34627684 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 469
Study 34627684 — intervention group
Group type: COMPARATOR
Intervention: Conventional infertility treatment
Number of subjects: 469
Study 33526728 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual antiplatelet treatment with aspirin 100‐160 mg once daily and clopidogrel 75 mg once daily for three months (Group A)
Number of subjects: 165
Study 33526728 — intervention group
Group type: COMPARATOR
Intervention: Aspirin 100‐160 mg once daily for three months (Group B)
Number of subjects: 165
Study 33526728 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group C) treated according to appropriate treatment guidelines
Number of subjects: 165
Study 34814819 — intervention group
Group type: EXPERIMENTAL
Intervention: Darbepoetin Alfa (DPA)
Number of subjects: 98
Study 34814819 — intervention group
Group type: COMPARATOR
Intervention: Epoetin Alfa (EPA)
Number of subjects: 98
Study 34814819 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments (DPA and EPA)
Number of subjects: 98
Study 34814819 — intervention group
Group type: EXPERIMENTAL
Intervention: C-Reactive Protein (CRP) measurement
Number of subjects: 98
Study 34464231 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal response adaptive design for treatment allocation
Number of subjects: 0
Study 34464231 — intervention group
Group type: COMPARATOR
Intervention: Fixed randomization (1:1 or 2:1)
Number of subjects: 0
Study 32014125 — intervention group
Group type: EXPERIMENTAL
Intervention: ropeginterferon alfa-2b
Number of subjects: 306
Study 32014125 — intervention group
Group type: COMPARATOR
Intervention: hydroxyurea
Number of subjects: 306
Study 34474433 — intervention group
Group type: EXPERIMENTAL
Intervention: CV̇O2 (42.49 ± 3.22 ml·kg−1·min−1)
Number of subjects: 9
Study 34474433 — intervention group
Group type: COMPARATOR
Intervention: CV̇O2slow (38.26 ± 2.43 ml·kg−1·min−1)
Number of subjects: 9
Study 36026699 — intervention group
Group type: EXPERIMENTAL
Intervention: Desensitizing mouth rinses (Colgate Sensitive, Elmex Sensitive Professional, Listerine Advanced Defense Sensitive, Sensodyne Cool Mint)
Number of subjects: 40
Study 36026699 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional mouth rinses (Colgate Plax, Elmex Caries Protection, Listerine Anticaries, Sensodyne Pronamel)
Number of subjects: 40
Study 36026699 — intervention group
Group type: COMPARATOR
Intervention: Positive control (Clinpro XT Varnish)
Number of subjects: 40
Study 36026699 — intervention group
Group type: COMPARATOR
Intervention: Negative control (distilled water)
Number of subjects: 40
Study 33896804 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic Manipulation Group (TMG:50)
Number of subjects: 80
Study 33896804 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG:30)
Number of subjects: 80
Study 32967775 — intervention group
Group type: EXPERIMENTAL
Intervention: Icosapent ethyl (IPE) 4 g daily (2 g BID with food)
Number of subjects: 13
Study 32967775 — intervention group
Group type: COMPARATOR
Intervention: Placebo (paraffin oil 2 g BID with food)
Number of subjects: 13
Study 35412878 — intervention group
Group type: EXPERIMENTAL
Intervention: Three Good Things exercise
Number of subjects: 126
Study 35412878 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 126
Study 33064247 — intervention group
Group type: EXPERIMENTAL
Intervention: Teaching emotive English bed-night tales
Number of subjects: 25
Study 33064247 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 25
Study 32219386 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin (10 mg once daily)
Number of subjects: 4744
Study 32219386 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4744
Study 616744462 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity training
Number of subjects: 0
Study 616744462 — intervention group
Group type: COMPARATOR
Intervention: Moderate-intensity training
Number of subjects: 0
Study 34756158 — intervention group
Group type: EXPERIMENTAL
Intervention: Propensity score-integrated power prior approach
Number of subjects: 0
Study 34756158 — intervention group
Group type: COMPARATOR
Intervention: Control arm from RCT
Number of subjects: 0
Study 34508656 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib
Number of subjects: 0
Study 34508656 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35849020 — intervention group
Group type: EXPERIMENTAL
Intervention: FAMily‐Oriented Support (FAMOS) family therapy program, includes seven home-based psychotherapeutic sessions
Number of subjects: 62
Study 35849020 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 62
Study 34218195 — intervention group
Group type: EXPERIMENTAL
Intervention: Driver feedback
Number of subjects: 174
Study 34218195 — intervention group
Group type: EXPERIMENTAL
Intervention: Driver feedback plus financial incentives
Number of subjects: 174
Study 34218195 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 174
Study 33465658 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention plus usual care
Number of subjects: 483
Study 33465658 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 483
Study 32557868 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted resistance training with instability
Number of subjects: 32
Study 32557868 — intervention group
Group type: COMPARATOR
Intervention: Traditional motor rehabilitation
Number of subjects: 32
Study 35979046 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led pain management based on the Precede-Proceed model
Number of subjects: 410
Study 35979046 — intervention group
Group type: COMPARATOR
Intervention: Conventional routine pain care (control group)
Number of subjects: 410
Study 33514300 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative examination of dyadic experience loss
Number of subjects: 29
Study 33514300 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-ended questions about the dyadic relationship
Number of subjects: 29
Study 33356580 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogen-rich water (HRW); six 30-min ankle baths throughout the first 24 hours post-injury, administered every 4 hours.
Number of subjects: 18
Study 33356580 — intervention group
Group type: COMPARATOR
Intervention: RICE protocol; rest, ice packs for 20 min every 3 hours, compression with elastic bandage for 24 hours, elevation above heart level.
Number of subjects: 18
Study 34057922 — intervention group
Group type: EXPERIMENTAL
Intervention: Pakistani almonds (10g/day for 12 weeks)
Number of subjects: 150
Study 34057922 — intervention group
Group type: EXPERIMENTAL
Intervention: American almonds (10g/day for 12 weeks)
Number of subjects: 150
Study 34057922 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 150
Study 33887475 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide oral suspension (BOS) 2.0 mg twice daily
Number of subjects: 318
Study 34218667 — intervention group
Group type: EXPERIMENTAL
Intervention: Stochastic, spatially resolved, transmission model (Global Epidemic and Mobility model)
Number of subjects: 100
Study 34218667 — intervention group
Group type: EXPERIMENTAL
Intervention: Different ranking strategies for site selection
Number of subjects: 100
Study 34218667 — intervention group
Group type: EXPERIMENTAL
Intervention: Proportional allocation of participants to sites based on projected incidence
Number of subjects: 100
Study 34218667 — intervention group
Group type: EXPERIMENTAL
Intervention: Geographically dispersed site combinations
Number of subjects: 100
Study 32783280 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid method (using loose seeds in combination with stranded seeds)
Number of subjects: 219
Study 32783280 — intervention group
Group type: COMPARATOR
Intervention: Conventional method (using loose seed alone)
Number of subjects: 219
Study 34470913 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (NaHCO3) supplementation (0.3 g/kg body mass) with warm-up
Number of subjects: 21
Study 34470913 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 21
Study 32871397 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week neuromuscular training program
Number of subjects: 24
Study 32871397 — intervention group
Group type: COMPARATOR
Intervention: Typical training routine (Control)
Number of subjects: 24
Study 32871397 — intervention group
Group type: COMPARATOR
Intervention: Comparison of experimental and control groups at post-testing
Number of subjects: 24
Study 35971801 — intervention group
Group type: EXPERIMENTAL
Intervention: miRNA-based prognostic model using miR-3147, miR-4513, and miR-4728-5p along with pathological T stage and Gleason score
Number of subjects: 295
Study 35971801 — intervention group
Group type: EXPERIMENTAL
Intervention: Low prediction index
Number of subjects: 295
Study 34424743 — intervention group
Group type: EXPERIMENTAL
Intervention: Er,Cr:YSGG laser
Number of subjects: 125
Study 34424743 — intervention group
Group type: COMPARATOR
Intervention: Tungsten carbide bur
Number of subjects: 125
Study 34424743 — intervention group
Group type: EXPERIMENTAL
Intervention: Finishing with laser beams (Er,Cr:YSGG, Waterlase) with polishing with Sof‐Lex discs
Number of subjects: 125